Search

everythinglearnresearchcommunity

for

Search:↓

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Promising cancer treatments were found, but the manufacturer closed.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Statins may help treat alopecia areata by reducing harmful immune interactions.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

mTOR inhibitors may help treat lung fibrosis.

Follistatin helps hair growth and cycling, while activin prevents it.

MR antagonists may improve skin health and wound healing, especially in aging.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

A mild botulinum toxin injection improved sperm production and movement in aging mice.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Acne patients have higher skin mTORC1 activity, which is reduced by isotretinoin treatment.

Antizyme slows skin tumor growth by reducing cell growth in mice.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

A new engineered treatment shows promise in curing heart fibrosis.

JAK inhibitors show promise in treating difficult skin diseases.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Noggin promotes skin tumors by activating Wnt and Shh pathways.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

A small BOTOX dose improved sperm production and movement in older mice.

FOL-005 peptide may help treat excessive hair growth safely.